The present invention provides isolated antibodies or antigen binding portions thereof which bind to CD1d. These antibodies and antigen binding portions thereof have application in treatment of conditions involving NKT cell effector function.
申请公布号
CA2850961(A1)
申请公布日期
2013.04.18
申请号
CA20122850961
申请日期
2012.10.15
申请人
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD.
发明人
NAMBIAR, JONATHAN KANNAN;POULTON, LYNN DOROTHY;CLARKE, ADAM;POW, ANDREW JAMES;TAMVAKIS, DEBRA;KOPSIDAS, GEORGE;DOYLE, ANTHONY GERARD;POLLARD, MATTHEW;MUSTAFA, HUSEYIN
